Matt Workentine retweeted
Check out our 2022 recap and 2023 outlook.
willowbio.com/press-releases…
We're hiring! Do you have the killer combo of bioinformatic skills and wet lab experience? Then come join us at @WillowBio ! willowbio.prismhr-hire.com/j…
1
1
Above link is no longer working. Please use this one: willowbio.prismhr-hire.com/j…
Matt Workentine retweeted
@WillowBio is very pleased to announce the signing of a Master Service Agreement with @KalsecInc for the development and manufacture of functional food ingredients, using the FutureGrown precision fermentation platform.
prnewswire.com/news-releases…
Matt Workentine retweeted
@willowbio announces the addition of a new pure, consistent and sustainable functional ingredient; FutureGrown Astaxanthin. This carotenoid is used in animal feed as a pigment, and in cosmetics & nutraceuticals for its powerful antioxidant properties.
prnewswire.com/news-releases…
Matt Workentine retweeted
Willow has incorporated Inscripta's Onyx Genome Engineering Platform into its strain engineering workflows. Read more in our press release here.
#FutureGrown #SynBio
prnewswire.com/news-releases…
Matt Workentine retweeted
Willow expands its portfolio with a new partnered pharmaceutical project demonstrating the wide array of opportunities accessible to Willow’s #FutureGrown technology platform.
willowbio.com/press-releases…
Matt Workentine retweeted
When you are not sure what the code does but assume it must be important so you just leave it
It’s my old job! Great opportunity to do cool analysis with cool people! I can’t think of anywhere else a bioinformatician get a to work on such a diverse range of projects.
This Post is from an account that no longer exists. Learn more
Matt Workentine retweeted
We are having a great 1st day at In-Cosmetics in Paris, discussing our new #heroingredient #CBG with the global cosmetics industry. Our friends @signumbio popped by to say hi!
Come visit us at B36
Matt Workentine retweeted
To further unlock the potential of cannabinoids, Willow has published the first peer reviewed article demonstrating the clinical benefit of #CBG for skincare
prn.to/3FJG8sW
The Next Generation of Nature is #FutureGrown
$WLLW $CANSF #synbio
Are you an R pro? Do you love building tools to help teams get the most out of their data? Come work with us at @WillowBio!
willowbio.prismhr-hire.com/j…
#RStats #bioinformatics
Matt Workentine retweeted
NEW: I wrote about Elisabeth Bik, a scientist turned science detective, and the time she challenged a prominent hydroxychloroquine crusader.
Their feud illustrates a larger truth that COVID has made all too clear: science often fails to police itself.
buzzfeednews.com/article/ste…
Matt Workentine retweeted
“What is America’s goal—to end the pandemic, or to suppress it to a level where it mostly plagues communities that privileged individuals can ignore?”
theatlantic.com/health/archi…
Matt Workentine retweeted
Today, we released our Q4 Earnings Report and 2020 year end results. We are pleased to announce that we have shortened timelines to commercialization of our biosynthesized CBG cannabinoid product and have a strong cash balance of $47.3M.
$WLLW
willowbio.com/press-releases…
Matt Workentine retweeted
An interdisciplinary team of McMaster researchers found that the chemical compound, or cannabinoid, called cannabigerol (CBG) is not only antibacterial but also effective in mice against the resilient bacteria, MRSA.
brighterworld.mcmaster.ca/ar…
#cannabinoids
Matt Workentine retweeted
Beginning with Cannabigerol (CBG) and other cannabinoids, our leading biotechnology platform allows us to deliver consistent, economical, sustainable ingredients at a global scale.
$WLLW
Come join @WillowBio as a part of our computational biology team!
ca.indeed.com/viewjob?t=scie…







